Vicente Alfaro

Summary

Affiliation: Universitat de Barcelona
Country: Spain

Publications

  1. ncbi request reprint Specification of laboratory animal use in scientific articles: current low detail in the journals' instructions for authors and some proposals
    V Alfaro
    Department of Physiology, Biology, University of Barcelona, Barcelona, Spain
    Methods Find Exp Clin Pharmacol 27:495-502. 2005
  2. ncbi request reprint [Clinical trials, good publication practice and legal regulations]
    Vicente Alfaro
    Departamento de Fisiologia, Universidad de Barcelona, Barcelona, Spain
    Med Clin (Barc) 123:100-3. 2004
  3. ncbi request reprint Role of histamine and platelet-activating factor in allergic rhinitis
    V Alfaro
    Department of Physiology, University of Barcelona, Avda Diagonal 645, 08028 Barcelona, Spain
    J Physiol Biochem 60:101-11. 2004
  4. pmc Abbreviated clinical study reports with investigational medicinal products for human use: current guidelines and recommendations
    Vicente Alfaro
    Universidad de Barcelona, Departamento de Fisiología Biología, Avenida Diagonal, 645, 08028 Barcelona, Spain
    Croat Med J 48:871-7. 2007
  5. ncbi request reprint [New proposals for improving the publication of clinical trials]
    Vicente Alfaro
    Med Clin (Barc) 123:677. 2004
  6. ncbi request reprint Gefitinib: current status in the treatment of non-small cell lung cancer
    Adnan Tanovic
    Department of Scientific Communications, Prous Science, Provença 388, 08025 Barcelona, Spain
    Drugs Today (Barc) 40:809-27. 2004
  7. ncbi request reprint [Clinical trial registration: new ICMJE requirement]
    Vicente Alfaro
    Med Clin (Barc) 124:638-9. 2005

Collaborators

  • Adnan Tanovic

Detail Information

Publications7

  1. ncbi request reprint Specification of laboratory animal use in scientific articles: current low detail in the journals' instructions for authors and some proposals
    V Alfaro
    Department of Physiology, Biology, University of Barcelona, Barcelona, Spain
    Methods Find Exp Clin Pharmacol 27:495-502. 2005
    ..These proposals are classified into major and minor issues, and they are located in the corresponding parts of the article, as defined by the Introduction, Methods, Results, and Discussion (IMRAD) method...
  2. ncbi request reprint [Clinical trials, good publication practice and legal regulations]
    Vicente Alfaro
    Departamento de Fisiologia, Universidad de Barcelona, Barcelona, Spain
    Med Clin (Barc) 123:100-3. 2004
  3. ncbi request reprint Role of histamine and platelet-activating factor in allergic rhinitis
    V Alfaro
    Department of Physiology, University of Barcelona, Avda Diagonal 645, 08028 Barcelona, Spain
    J Physiol Biochem 60:101-11. 2004
    ..Apart from leukotrienes, PAF is perhaps the most potent inflammatory mediator in allergic rhinitis for inducing vascular leakage, a response that may contribute to the appearance of rhinorrhea and nasal congestion...
  4. pmc Abbreviated clinical study reports with investigational medicinal products for human use: current guidelines and recommendations
    Vicente Alfaro
    Universidad de Barcelona, Departamento de Fisiología Biología, Avenida Diagonal, 645, 08028 Barcelona, Spain
    Croat Med J 48:871-7. 2007
  5. ncbi request reprint [New proposals for improving the publication of clinical trials]
    Vicente Alfaro
    Med Clin (Barc) 123:677. 2004
  6. ncbi request reprint Gefitinib: current status in the treatment of non-small cell lung cancer
    Adnan Tanovic
    Department of Scientific Communications, Prous Science, Provença 388, 08025 Barcelona, Spain
    Drugs Today (Barc) 40:809-27. 2004
    ..This review provides currently available data from clinical studies on gefitinib as monotherapy or in combination with platinum-containing chemotherapy...
  7. ncbi request reprint [Clinical trial registration: new ICMJE requirement]
    Vicente Alfaro
    Med Clin (Barc) 124:638-9. 2005